The cornea is the transparent, protective outermost layer of the eye that acts as a barrier against dirt, germs and particles that may damage the delicate components of the eye. In case the cornea would suffer a deep damage, the healing process may be prolonged, causing pain, blurred sight, lacrimation, redness, excessive light sensitivity and corneal healing. The treatment for corneal erosion is the occlusion of the eye, along with the administration of antibiotics for preventing infections the use of anesthetics will delay healing and unchain a recurrent erosion difficult to cure. None of the drugs currently available on the market for treating corneal regeneration contain growth factors that facilitate this process. Therefore, a pharmaceutical composition has been developed, which is obtained by the mixture of a platelet lysate and trans-pheromones with an important regenerative activity over a cornea with mechanical or chemical damage in healthy people or people suffering from di abetes mellitus. The present invention provides the unique alternative of having, in a simultaneous manner, growth factors promoting the cellular regeneration and a vehicle for incorporating analgesics, antibiotics and/or anti-inflammatories, thus facilitating the topic application thereof and increasing the shelf life of the product.La córnea es la capa transparente, protectora más externa del ojo que funciona como una barrera contra la suciedad, gérmenes, y partículas que pueden dañar los componentes delicados del ojo. En caso de un daño profundo de la córnea, el proceso de curación puede ser prolongado, provocando dolor, visión borrosa, lagrimeo, enrojecimiento, extrema sensibilidad a la luz y cicatrización corneal. El tratamiento de la erosión corneal es la oclusión del ojo, prescribiéndose simultáneamente antibióticos para prevenir la infección, mientras que el uso de anestésico retrasa la cicatrización, desencadenando una erosión recurrente de más difícil curación. Ninguno de los
